N/A N=148 STIM+: PET Biomarker Education & Disclosure
Mild Cognitive Impairment · Dementia; Alzheimer's Type (Etiology)
Primary: Participant Interest in PET Biomarker Disclosure — 73 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=12 High-Intensity Interval Training to Improve Symptoms of Deployment-Related Respiratory Disease
Occupational Exposure
Primary: Maximum Oxygen Consumption (VO2max) — 26.4 ml/kg/min
Phase 3 N=138 Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas
Brain Tumor, Primary · Brain Tumor, Recurrent
Primary: Diagnostic Quality of Cerebral Blood Volume (CBV) Map of Dynamic Susceptibility Contrast MRI (DSC-MRI) Perfusion — 58; 63 Participants
N/A N=173 The HARMONY Study: A Intervention to Reduce Cardiometabolic Risk in African American Women
Heart Diseases · Stroke · Pre-diabetes
Primary: Change in Amount of Moderate to Vigorous Physical Activity — -5.89; -11.24 minutes/day
Phase 1 N=244 Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer
Health, Subjective
Primary: Incidence Rate of Drug Allergy Following ID Injection of the IP — 0; 0; 1; 0 Participants
N/A N=1,083 Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Metastatic Castration Resistant Prostate Cancer (mCRPC)
Primary: Body Mass Index (BMI) — 27.9; 27.1 Kilogram per meter square
N/A N=52 Ponto Implantation Using a Minimally Invasive Surgical Technique
Hearing Loss
Primary: Number of Implants With Reliable Anchorage for a Sound Processor — 49 Implants
Phase 2 N=60 CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations
Advanced Solid Tumor Malignancy
Primary: Type and Number of Adverse Events (AEs) — 24; 37; 62; 143 number of events
N/A N=24 Study to Evaluate the Safety and Effectiveness of Dayspring for Lower Extremity Lymphedema
Lymphedema · Lymphedema Lower Extremity · Chronic Venous Insufficiency
Primary: LYMQOL (LYMphedema Quality of Life) ***All Relevant Time Points Used in the Calculation in the Time Frame (e.g., Baseline and 3 Months).*** — .83 units on a scale
N/A N=151 A Skin Glue Versus Subcuticular Suture for Cesarean Closure Study
Cesarean Section · Complication · Wound
Primary: Patient Scar Satisfaction Scale Score — 13; 13.5 score on a scale
N/A N=226 The Getting Off App for Methamphetamine-Using Gay and Bisexual Men
Methamphetamine Abuse · HIV/AIDS
Primary: Methamphetamine Use — 13.6; 15.3; 10.9; 14.5 days
Phase 2 N=86 A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Primary: Period A (DB Period): Percentage of Biologic and Small Molecule Immunosuppressive-Naïve Participants Who Achieved Hidradenitis Suppurativa Clinical Response (HiSCR50) at…
N/A N=53 Efficacy of Arnica Montana in Reducing Postoperative Edema and Pain
Arnica · Third Molar Extraction
Primary: Change in Postoperative Facial Swelling From Baseline to Day 3 — 9.2508; 9.3320; 7.4336; 7.0346 cm^2
N/A N=40 Incentive-based and Media Literacy Informed Approaches to Improve Vaping Cessation
Behavior, Health Risk · Implementation Science · E Cigarette Use
Primary: Engagement_remote checkin_3 — 6; 5; 6; 5 Participants — p=0.820
N/A N=9 Respiratory Muscle Training (RMT) in ALS
ALS
Primary: Number of Participants With Safe, Well-tolerated Moderate Intensity Respiratory Muscle Training (RMT) as Measured by Rating of Perceived Exertion (RPE) — 4 Participants